Navigation Links
Infinitus Clinical Research Consolidates - Sino-Indian CRO Enhances Core Capabilities
Date:3/17/2010

BANGALORE, India, March 17, 2010 /PRNewswire/ -- Infinitus Clinical Research is continuing to pioneer its unique strategy. This is based on the following elements:

"As former Vice-President for clinical drug development with a major US Pharma company" said CEO, Roy Drucker, "I was frustrated by the unexploited potential of India and China. Large Western CROs were inevitably forced to give up part of the cost advantage of those countries because of operating expense back at base camp. The best local players scored better on price and satisfied study deadline requirements but were incapable of assuming a product development partnership role. We strive to deliver the best of both worlds at Infinitus. "

    "Our conviction is that excellent medical science underpins excellent
    clinical research and education. This is reflected in our ongoing
    collaborative relationship with the Department of Pharmacology at the
    University of Oxford, where we have a Coordinating Centre. We recognize
    that a significant part of our client base is in the USA and our North
    American office will open shortly. We are also progressing a major
    oncology initiative which will enable Infinitus to deliver unparalleled
    speed, quality and prices for studies in all phases."

"Infinitus has also recognized the opacity of India and China to smaller Western companies wishing to conduct product or corporate transactions in these countries. With established strategic partners in both locations we are currently working with clients who have products for which they are seeking to achieve marketing presence in India and China, as well as executing M&A mandates on behalf of Western clients. More recently, we have begun to serve the needs of Chinese clients wishing to bring their products to the West."

Roy Drucker: "The world of clinical product development is changing very rapidly and there are huge advantages available to those who are prepared to explore unfamiliar territory. Infinitus can make that exploration a positive experience."

About Infinitus:

Infinitus executes its clinical research activities exclusively in Asia.

Benefitting from not having to bear the overheads of a large western infrastructure, the orientation is very much towards serving the needs of an international clientele which includes early stage life science companies researching pharmaceutical and biotechnology products as well as medical devices.

Operating out of Bangalore in India and Nanjing in China, it is led by a management team with extensive experience of conceiving and executing entire clinical product development programmes for global registration purposes, as well as substantial hands-on operational experience in the relevant territory.

Its objective is to assist in curtailing the cost of product development in its clinical stages while at the same time expediting execution and adding value in every way possible.

    Infinitus' product candidate and program evaluation services are used as
    decision support tools by investors prior to investment or to guide
    investment decisions, and by pharmaceutical companies prior to committing
    their resources to clinical programs for candidates developed in-house or
    before in-licensing candidates. It is supported by all members of our
    Scientific Advisory Board.



    Media Contact:
    Dr Shailendra
    Tel: +91-80-40051521
    http://www.infinitusglobal.com
    E-mail: bd@infinitusglobal.com/ shailendra@infinitusglobal.com/
    varada@infinitusglobal.com


SOURCE Infinitus Clinical Research Pvt. Ltd.

Back to top
'/>"/>
SOURCE Infinitus Clinical Research Pvt. Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Infinitus Clinical Research Consolidates- Sino-Indian CRO Enhances Core Capabilities
2. CorMatrix Announces Publication of Pre-Clinical Data in Journal of American College of Cardiology (JACC) Demonstrating the Role of CorMatrix ECM(TM) Technology in Remodeling Cardiac Tissue
3. ERT Launches Centralized Cardiac Safety 2.0: A Revolutionary New Approach to ECG Management in Clinical Trials
4. Stryker Launches New Technologies and Celebrates a Major Clinical Milestone at The American Academy of Orthopaedic Surgeons Conference
5. Cellectar Completes Enrollment in Phase I Clinical Trial of Lead Drug Candidate (131)I-CLR1404 for the Treatment of Solid Malignancies
6. ISIS Initiates Phase 1 Clinical Trial of ISIS-SOD1Rx in Patients With ALS
7. ReShape Medical Announces Initiation of U.S. Clinical Study for Weight Loss
8. TechniScan Launches 3-D Breast Ultrasound Clinical Study in Freiburg University
9. Carefx to Provide Clinical Workflow Solutions for Military Health System
10. Cardio3 BioSciences Announces Promising Pre-Clinical Data for Proprietary C-Cath(R) Catheter
11. WuXi PharmaTech Enters into Collaboration with J&JPRD, a division of Janssen Pharmaceutica for Preclinical Services and Training
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that it will ... at the Sheraton Hotel in Toronto, Ontario . ... Company is scheduled to present on Tuesday, May 2 at 10:00 ... of the Board, Tony Holler will also attend the ... For more details about ...
(Date:4/19/2017)... MOUNTAIN VIEW, Calif. , April 19, 2017 /PRNewswire/ ... that it will release financial results for the first ... May 3, 2017.  The Company,s management team will host ... / 5:30 p.m. ET. Investors interested in ... dialing (844) 707-0665 for domestic callers or (703) 326-3030 ...
(Date:4/19/2017)... , Tenn. and DALLAS , April 19, ... Inc., announced that the first patients in ... EndoStim device in the Lower Esophageal Sphincter Stimulation for ... minimally-invasive implantable device designed to provide long-term reflux control ... GERD affects nearly 65 million people in ...
Breaking Medicine Technology:
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... The Patient ... Baltimore Health System, with the 2017 Ruth Ravich Patient Advocacy Award in ... patient advocates. DeVaro was honored with the award at The Beryl Institute’s annual ...
(Date:4/21/2017)... ... April 21, 2017 , ... The ... A Week of Addiction and Recovery Education, from April 24 to April 28, ... substance use disorders. , The mission of AWARE is to instill a ...
(Date:4/21/2017)... UK (PRWEB) , ... April 21, 2017 , ... ... for Enterprise in the category of International Trade, the UK’s most prestigious award ... international trade, which represents 95% of total revenues and has grown by a ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... Westside ... experienced, personalized dental care since 1985. After thirty-two years, Dr. Latner has become one ... to help my numerous clients over the years with all their dental needs,” said ...
(Date:4/21/2017)... ... April 21, 2017 , ... Federal ... five common elements between the Obamacare program that most Republicans love to hate ... Warfarin poison to kill hogs. , Like Obamacare, the Miller program centers ...
Breaking Medicine News(10 mins):